The GOP Congress and President Donald Trump spent very little time discussing the broader implications of the tax cut-Medicaid cut bill. As such, it did a disservice to all taxpayers in this ...

But in the states that have tried them, Medicaid work requirements did little to boost employment. Instead, they created ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so.

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

More than 60 parents, assemblymembers and youth mental health advocates called upon New York State lawmakers to compensate ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

U.S. Rep. Eric Sorensen spoke against patient loss of Medicaid coverage during a tour of a OSF HealthCare facility in Peoria.

Health insurance companies that sell plans in the individual market are requesting to increase their rates by an average of ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...